Henry Schein Announces Divestiture of Noncontrolling Interest in Dental Wholesale Distributor

   Henry Schein Announces Divestiture of Noncontrolling Interest in Dental
                            Wholesale Distributor

PR Newswire

MELVILLE, N.Y., July 10, 2013

MELVILLE, N.Y., July 10, 2013 /PRNewswire/ --Henry Schein, Inc. (NASDAQ:
HSIC), the world's largest provider of health care products and services to
office-based dental, medical and animal health practitioners, announced today
that it has divested its investment in a dental wholesale distributor in the
Middle East. The investment was an unprofitable, noncontrolling interest in
an entity that primarily served as an importer that distributed products
largely to other distributors.

The divestiture is expected to generate a one-time charge in the range of $11
million to $13 million, or 13 cents to 15 cents per diluted share, in the
third quarter of 2013. Henry Schein will show third quarter earnings results
excluding the impact of this loss in order to provide more meaningful
year-on-year comparisons of the Company`s core financial performance.

"Henry Schein's strategic plan is focused on growing our presence as the
leading global distributor of products and related value added services in the
market segments we serve," said Stanley M. Bergman, Chairman of the Board and
Chief Executive Officer of Henry Schein. "As part of that plan, we have
elected to divest our interest in this non-core holding to further align our
investments targeting our primary customer base, the office-based

About Henry Schein, Inc.

Henry Schein, Inc. is the world's largest provider of health care products and
services to office-based dental, medical and animal health practitioners. The
Company also serves dental laboratories, government and institutional health
care clinics, and other alternate care sites. A Fortune 500® Company and a
member of the NASDAQ 100® Index, Henry Schein employs more than 15,500 Team
Schein Members and serves more than 775,000 customers.

The Company offers a comprehensive selection of products and services,
including value-added solutions for operating efficient practices and
delivering high-quality care. Henry Schein operates through a centralized and
automated distribution network, with a selection of more than 96,000 branded
products and Henry Schein private-brand products in stock, as well as more
than 110,000 additional products available as special-order items.

The Company also offers its customers exclusive, innovative technology
solutions, including practice management software and e-commerce solutions, as
well as a broad range of financial services.

Headquartered in Melville, N.Y., Henry Schein has operations or affiliates in
24 countries. The Company's sales reached a record $8.9 billion in 2012, and
have grown at a compound annual rate of 17% since Henry Schein became a public
company in 1995. For more information, visit the Henry Schein Web site at

Cautionary Note Regarding Forward-Looking Statements

In accordance with the "Safe Harbor" provisions of the Private Securities
Litigation Reform Act of 1995, we provide the following cautionary remarks
regarding important factors that, among others, could cause future results to
differ materially from the forward-looking statements, expectations and
assumptions expressed or implied herein. All forward-looking statements made
by us are subject to risks and uncertainties and are not guarantees of future
performance. These forward-looking statements involve known and unknown
risks, uncertainties and other factors that may cause our actual results,
performance and achievements or industry results to be materially different
from any future results, performance or achievements expressed or implied by
such forward-looking statements. These statements are identified by the use
of such terms as "may," "could," "expect," "intend," "believe," "plan,"
"estimate," "forecast," "project," "anticipate" or other comparable terms. A
full discussion of our operations and financial condition, including factors
that may affect our business and future prospects, is contained in documents
we have filed with the SEC and will be contained in all subsequent periodic
filings we make with the SEC. These documents identify in detail important
risk factors that could cause our actual performance to differ materially from
current expectations.

Risk factors and uncertainties that could cause actual results to differ
materially from current and historical results include, but are not limited
to: effects of a highly competitive market; our dependence on third parties
for the manufacture and supply of our products; our dependence upon sales
personnel, customers, suppliers and manufacturers; our dependence on our
senior management; fluctuations in quarterly earnings; risks from expansion of
customer purchasing power and multi-tiered costing structures; possible
increases in the cost of shipping our products or other service issues with
our third-party shippers; general global macro-economic conditions;
disruptions in financial markets; possible volatility of the market price of
our common stock; changes in the health care industry; implementation of
health care laws; failure to comply with regulatory requirements and data
privacy laws; risks associated with our global operations; transitional
challenges associated with acquisitions and joint ventures, including the
failure to achieve anticipated synergies; financial risks associated with
acquisitions and joint ventures; litigation risks; the dependence on our
continued product development, technical support and successful marketing in
the technology segment; risks from rapid technological change; risks from
disruption to our information systems; certain provisions in our governing
documents that may discourage third-party acquisitions of us; and changes in
tax legislation. The order in which these factors appear should not be
construed to indicate their relative importance or priority.

We caution that these factors may not be exhaustive and that many of these
factors are beyond our ability to control or predict. Accordingly, any
forward-looking statements contained herein should not be relied upon as a
prediction of actual results. We undertake no duty and have no obligation to
update forward-looking statements.

SOURCE Henry Schein, Inc.

Website: http://www.henryschein.com
Contact: Investors: Steven Paladino, Executive Vice President and Chief
Financial Officer, steven.paladino@henryschein.com, (631) 843-5500, or
Carolynne Borders, Vice President, Investor Relations,
carolynne.borders@henryschein.com, (631) 390-8105; Media: Susan Vassallo, Vice
President, Corporate Communications, susan.vassallo@henryschein.com, (631)
Press spacebar to pause and continue. Press esc to stop.